Literature DB >> 21880755

Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children.

Rogier Bodewes1, Pieter L A Fraaij, Martina M Geelhoed-Mieras, Carel A van Baalen, Harm A W M Tiddens, Annemarie M C van Rossum, Fiona R van der Klis, Ron A M Fouchier, Albert D M E Osterhaus, Guus F Rimmelzwaan.   

Abstract

Infection with seasonal influenza A viruses induces immunity to potentially pandemic influenza A viruses of other subtypes (heterosubtypic immunity). We recently demonstrated that vaccination against seasonal influenza prevented the induction of heterosubtypic immunity against influenza A/H5N1 virus induced by infection with seasonal influenza in animal models, which correlated with the absence of virus-specific CD8(+) T cell responses. Annual vaccination of all healthy children against influenza has been recommended, but the impact of vaccination on the development of the virus-specific CD8(+) T cell immunity in children is currently unknown. Here we compared the virus-specific CD8(+) T cell immunity in children vaccinated annually with that in unvaccinated children. In the present study, we compared influenza A virus-specific cellular and humoral responses of unvaccinated healthy control children with those of children with cystic fibrosis (CF) who were vaccinated annually. Similar virus-specific CD4(+) T cell and antibody responses were observed, while an age-dependent increase of the virus-specific CD8(+) T cell response that was absent in vaccinated CF children was observed in unvaccinated healthy control children. Our results indicate that annual influenza vaccination is effective against seasonal influenza but hampers the development of virus-specific CD8(+) T cell responses. The consequences of these findings are discussed in the light of the development of protective immunity to seasonal and future pandemic influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880755      PMCID: PMC3209321          DOI: 10.1128/JVI.05213-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  CD4+ and CD8+ cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age.

Authors:  J Chipeta; Y Komada; X L Zhang; T Deguchi; K Sugiyama; E Azuma; M Sakurai
Journal:  Cell Immunol       Date:  1998-02-01       Impact factor: 4.868

2.  Live attenuated versus inactivated influenza vaccine in infants and young children.

Authors:  Robert B Belshe; Kathryn M Edwards; Timo Vesikari; Steven V Black; Robert E Walker; Micki Hultquist; George Kemble; Edward M Connor
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

3.  Cost-effectiveness of influenza vaccination of healthy children.

Authors:  Heini Salo; Terhi Kilpi; Harri Sintonen; Miika Linna; Ville Peltola; Terho Heikkinen
Journal:  Vaccine       Date:  2006-04-07       Impact factor: 3.641

4.  Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

Authors:  J H C M Kreijtz; R Bodewes; G van Amerongen; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Vaccine       Date:  2006-09-07       Impact factor: 3.641

Review 5.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

6.  Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; Naveed Z Janjua; Nicole Boulianne; Travis S Hottes; Laura C Rosella; James A Dickinson; Rodica Gilca; Pam Sethi; Najwa Ouhoummane; Donald J Willison; Isabelle Rouleau; Martin Petric; Kevin Fonseca; Steven J Drews; Anuradha Rebbapragada; Hugues Charest; Marie-Eve Hamelin; Guy Boivin; Jennifer L Gardy; Yan Li; Trijntje L Kwindt; David M Patrick; Robert C Brunham
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

7.  Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus.

Authors:  J H C M Kreijtz; G de Mutsert; C A van Baalen; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  Yearly influenza vaccinations: a double-edged sword?

Authors:  Rogier Bodewes; Joost H C M Kreijtz; Guus F Rimmelzwaan
Journal:  Lancet Infect Dis       Date:  2009-10-30       Impact factor: 25.071

9.  Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.

Authors:  Heng Ding; Cheguo Tsai; Fan Zhou; Philippe Buchy; Vincent Deubel; Paul Zhou
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

10.  Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada.

Authors:  Naveed Z Janjua; Danuta M Skowronski; Travis S Hottes; William Osei; Evan Adams; Martin Petric; Suzana Sabaiduc; Tracy Chan; Annie Mak; Marcus Lem; Patrick Tang; David M Patrick; Gaston De Serres; David Bowering
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

View more
  41 in total

Review 1.  A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.

Authors:  Herve Caspard; Terho Heikkinen; Robert B Belshe; Christopher S Ambrose
Journal:  Hum Vaccin Immunother       Date:  2016-07-02       Impact factor: 3.452

2.  Influenza vaccination in children at high risk of respiratory disease.

Authors:  Maria Francesca Patria; Claudia Tagliabue; Benedetta Longhi; Susanna Esposito
Journal:  Ther Adv Vaccines       Date:  2013-05

3.  Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Authors:  Danuta M Skowronski; Catharine Chambers; Gaston De Serres; Suzana Sabaiduc; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Kevin Fonseca; Steven J Drews; Hugues Charest; Christine Martineau; Mel Krajden; Martin Petric; Nathalie Bastien; Yan Li; Derek J Smith
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

4.  Local poultry biosecurity risks to highly pathogenic avian influenza in Kaduna State, Nigeria.

Authors:  Abdu A Paul; Assam Assam; Tabe-Ntui L Ndang
Journal:  Trop Anim Health Prod       Date:  2012-08-07       Impact factor: 1.559

5.  Impact of Repeated Influenza Immunization on Respiratory Illness in Children With Preexisting Medical Conditions.

Authors:  Marieke L A de Hoog; Roderick P Venekamp; Roger A M J Damoiseaux; Anne G M Schilder; Elisabeth A M Sanders; Henriette A Smit; Patricia C J L Bruijning-Verhagen
Journal:  Ann Fam Med       Date:  2019-01       Impact factor: 5.166

6.  Human Influenza A Virus-Specific CD8+ T-Cell Response Is Long-lived.

Authors:  Carolien E van de Sandt; Marine L B Hillaire; Martina M Geelhoed-Mieras; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2015-01-12       Impact factor: 5.226

7.  High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.

Authors:  Jin Hyang Kim; H Keipp Talbot; Margarita Mishina; Yuwei Zhu; Jufu Chen; Weiping Cao; Adrian J Reber; Marie R Griffin; David K Shay; Sarah M Spencer; Suryaprakash Sambhara
Journal:  Vaccine       Date:  2016-07-26       Impact factor: 3.641

8.  Cellular immune correlates of protection against symptomatic pandemic influenza.

Authors:  Saranya Sridhar; Shaima Begom; Alison Bermingham; Katja Hoschler; Walt Adamson; William Carman; Thomas Bean; Wendy Barclay; Jonathan J Deeks; Ajit Lalvani
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

Review 9.  Early programming and late-acting checkpoints governing the development of CD4 T-cell memory.

Authors:  Kunal Dhume; Karl Kai McKinstry
Journal:  Immunology       Date:  2018-05-21       Impact factor: 7.397

10.  Characterization of the human CD8⁺ T cell response following infection with 2009 pandemic influenza H1N1 virus.

Authors:  M L B Hillaire; S E van Trierum; R Bodewes; C A van Baalen; R S van Binnendijk; M P Koopmans; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.